![evaluate the pharmaceuticals company saxenda on glp-1 cost Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in United States Oral GLP-1 Market to Rise](https://photos.prnewswire.com/prnfull/20150421/200098)
evaluate the pharmaceuticals company saxenda on glp-1 cost
Shipping Estimate
evaluate the pharmaceuticals company saxenda on glp-1 cost Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in United States Oral GLP-1 Market to Rise
USD21.24
USD63.24
Pay in 4 interest-free payments of $5.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 9 - Sep 14
![evaluate the pharmaceuticals company saxenda on glp-1 cost Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States Oral GLP-1 Market to Rise](https://www.towardshealthcare.com/insightimg/oral-glp-1-market-size.webp)
![evaluate the pharmaceuticals company saxenda on glp-1 cost Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States Oral GLP-1 Market to Rise](https://familycaremurphy.com/wp-content/uploads/2025/12/GLP-1-Weight-Loss-Medication-Guide-Choosing-Between-Wegovy-Ozempic-Saxenda.jpg)
![evaluate the pharmaceuticals company saxenda on glp-1 cost Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States Oral GLP-1 Market to Rise](https://plushcare.com/hs-fs/hubfs/Saxenda%C2%AE%20-%201600x800px.webp?width=1600&height=800&name=Saxenda%C2%AE%20-%201600x800px.webp)
![evaluate the pharmaceuticals company saxenda on glp-1 cost Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States Oral GLP-1 Market to Rise](https://betteryourx.com/wp-content/uploads/2026/01/Wegovy-vs-Saxenda-Which-Weight-Loss-Injection-Works-Better.jpg)
![evaluate the pharmaceuticals company saxenda on glp-1 cost Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States Oral GLP-1 Market to Rise](https://img.datawrapper.de/ZJY39/full.png)
![evaluate the pharmaceuticals company saxenda on glp-1 cost Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States Oral GLP-1 Market to Rise](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2025/09/GettyImages-2162809200-430x241.jpg)
